Anti-DDAH2 antibody [R09-8U1] (STJA0036647)

SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenA synthesized peptide derived from human DDAH2
STJA0036647
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit monoclonal anti-DDAH2 for use in WB and IP in Human, Mouse and Rat samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsWB/IP
HostRabbit
ReactivityHuman/Mouse/Rat
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDR09-8U1
IsotypeIgG
ConjugationUnconjugated
PurificationAffinity Chromatography
Dilution RangeWB 1:500-1:1000
IP 1:50
FormulationRabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Storage InstructionStore at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles.

Target Information

Gene SymbolDDAH2
Gene ID23564
Uniprot IDDDAH2_HUMAN
ImmunogenA synthesized peptide derived from human DDAH2

Additional Info

Tissue Specificity Detected in heart, placenta, lung, liver, skeletal muscle, kidney and pancreas, and at very low levels in brain.
Post Translational Modifications Phosphorylated by TBK1. Phosphorylation inhibits the translocation into the mitochondrion upon Sendai viral infection.
Function Putative hydrolase with unknown substrate (Probable). Does not hydrolyze N(G),N(G)-dimethyl-L-arginine (ADMA) which acts as an inhibitor of NOS. In endothelial cells, induces expression of vascular endothelial growth factor (VEGF) via phosphorylation of the transcription factor SP1 by PKA in a process that is independent of NO and NO synthase. Similarly, enhances pancreatic insulin secretion through SP1-mediated transcriptional up-regulation of secretagogin/SCGN, an insulin vesicle docking protein. Upon viral infection, relocates to mitochondria where it promotes mitochondrial fission through activation of DNM1L leading to the inhibition of innate response activation mediated by MAVS.
Protein Name Putative Hydrolase Ddah2
Ddahii
Inactive N(G -N(G-Dimethylarginine Dimethylaminohydrolase 2
Ddah-2
Inactive Dimethylarginine Dimethylaminohydrolase 2
Protein G6a
S-Phase Protein
Database Links
Cellular Localisation Cytoplasm
Mitochondrion
Translocates From Cytosol To Mitochondrion Upon Il1b Stimulation In Chondrocytes
(Microbial Infection) Translocates To The Mitochondrion Upon Sendai Viral Infection
Alternative Antibody Names Anti-Putative Hydrolase Ddah2 antibody
Anti-Ddahii antibody
Anti-Inactive N(G -N(G-Dimethylarginine Dimethylaminohydrolase 2 antibody
Anti-Ddah-2 antibody
Anti-Inactive Dimethylarginine Dimethylaminohydrolase 2 antibody
Anti-Protein G6a antibody
Anti-S-Phase Protein antibody
Anti-DDAH2 antibody
Anti-DDAH antibody
Anti-G6A antibody
Anti-NG30 antibody

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins